The volume treats the wide diffusion of the endovascular techniques in the treatment of different diseases involving the thoracic (TEVAR) and abdominal aorta (EVAR), which represent a great revolution in vascular surgery. On the other hand they have led to the birth of a new category of patients: those affected by early and late complications after EVAR and TEVAR. Since their appearance, the management of these patients seemed to be complex and technically demanding. As for traditional surgery, redo procedures require a high level of expertise and skill. However, from both randomized controlled trials and large single-center experiences, it appeared soon evident the much higher rate of reintervention after endovascular procedures than open repair. So it leads to a very large number of patients who need a new treatment during their follow-up. Fortunately the majority of these complications can be successfully managed with a new endovascular procedure. Furthermore, the Type II endoleak, once indicated as the Achille’s heel of EVAR, is losing its importance, although it is gaining even more popularity. And again, new materials and devices are expected to reduce the rate of complications over time.
EVAR and TEVAR: wrong planning of the procedure
Verzini F
2012-01-01
Abstract
The volume treats the wide diffusion of the endovascular techniques in the treatment of different diseases involving the thoracic (TEVAR) and abdominal aorta (EVAR), which represent a great revolution in vascular surgery. On the other hand they have led to the birth of a new category of patients: those affected by early and late complications after EVAR and TEVAR. Since their appearance, the management of these patients seemed to be complex and technically demanding. As for traditional surgery, redo procedures require a high level of expertise and skill. However, from both randomized controlled trials and large single-center experiences, it appeared soon evident the much higher rate of reintervention after endovascular procedures than open repair. So it leads to a very large number of patients who need a new treatment during their follow-up. Fortunately the majority of these complications can be successfully managed with a new endovascular procedure. Furthermore, the Type II endoleak, once indicated as the Achille’s heel of EVAR, is losing its importance, although it is gaining even more popularity. And again, new materials and devices are expected to reduce the rate of complications over time.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
